Request for Covid-19 Impact Assessment of this Report
The United States Adult and Pediatric Vaccines market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Adult and Pediatric Vaccines market, reaching US$ million by the year 2028. As for the Europe Adult and Pediatric Vaccines landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Adult and Pediatric Vaccines players cover GlaxoSmithKline, Sanofi, Merck, and Novartis, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Adult and Pediatric Vaccines market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Adult Vaccines
Pediatric Vaccines
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospitals
Medical Care Centers
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
GlaxoSmithKline
Sanofi
Merck
Novartis
Pfizer
AstraZeneca
Johnson and Johnson
Takeda Pharmaceutical
Bavarian Nordic
LG Life Sciences
Sinovac Biotech
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Adult and Pediatric Vaccines Market Size 2017-2028
2.1.2 Adult and Pediatric Vaccines Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Adult and Pediatric Vaccines Segment by Type
2.2.1 Adult Vaccines
2.2.2 Pediatric Vaccines
2.3 Adult and Pediatric Vaccines Market Size by Type
2.3.1 Adult and Pediatric Vaccines Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Adult and Pediatric Vaccines Market Size Market Share by Type (2017-2022)
2.4 Adult and Pediatric Vaccines Segment by Application
2.4.1 Hospitals
2.4.2 Medical Care Centers
2.4.3 Others
2.5 Adult and Pediatric Vaccines Market Size by Application
2.5.1 Adult and Pediatric Vaccines Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Adult and Pediatric Vaccines Market Size Market Share by Application (2017-2022)
3 Adult and Pediatric Vaccines Market Size by Player
3.1 Adult and Pediatric Vaccines Market Size Market Share by Players
3.1.1 Global Adult and Pediatric Vaccines Revenue by Players (2020-2022)
3.1.2 Global Adult and Pediatric Vaccines Revenue Market Share by Players (2020-2022)
3.2 Global Adult and Pediatric Vaccines Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Adult and Pediatric Vaccines by Regions
4.1 Adult and Pediatric Vaccines Market Size by Regions (2017-2022)
4.2 Americas Adult and Pediatric Vaccines Market Size Growth (2017-2022)
4.3 APAC Adult and Pediatric Vaccines Market Size Growth (2017-2022)
4.4 Europe Adult and Pediatric Vaccines Market Size Growth (2017-2022)
4.5 Middle East & Africa Adult and Pediatric Vaccines Market Size Growth (2017-2022)
5 Americas
5.1 Americas Adult and Pediatric Vaccines Market Size by Country (2017-2022)
5.2 Americas Adult and Pediatric Vaccines Market Size by Type (2017-2022)
5.3 Americas Adult and Pediatric Vaccines Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Adult and Pediatric Vaccines Market Size by Region (2017-2022)
6.2 APAC Adult and Pediatric Vaccines Market Size by Type (2017-2022)
6.3 APAC Adult and Pediatric Vaccines Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Adult and Pediatric Vaccines by Country (2017-2022)
7.2 Europe Adult and Pediatric Vaccines Market Size by Type (2017-2022)
7.3 Europe Adult and Pediatric Vaccines Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Adult and Pediatric Vaccines by Region (2017-2022)
8.2 Middle East & Africa Adult and Pediatric Vaccines Market Size by Type (2017-2022)
8.3 Middle East & Africa Adult and Pediatric Vaccines Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Adult and Pediatric Vaccines Market Forecast
10.1 Global Adult and Pediatric Vaccines Forecast by Regions (2023-2028)
10.1.1 Global Adult and Pediatric Vaccines Forecast by Regions (2023-2028)
10.1.2 Americas Adult and Pediatric Vaccines Forecast
10.1.3 APAC Adult and Pediatric Vaccines Forecast
10.1.4 Europe Adult and Pediatric Vaccines Forecast
10.1.5 Middle East & Africa Adult and Pediatric Vaccines Forecast
10.2 Americas Adult and Pediatric Vaccines Forecast by Country (2023-2028)
10.2.1 United States Adult and Pediatric Vaccines Market Forecast
10.2.2 Canada Adult and Pediatric Vaccines Market Forecast
10.2.3 Mexico Adult and Pediatric Vaccines Market Forecast
10.2.4 Brazil Adult and Pediatric Vaccines Market Forecast
10.3 APAC Adult and Pediatric Vaccines Forecast by Region (2023-2028)
10.3.1 China Adult and Pediatric Vaccines Market Forecast
10.3.2 Japan Adult and Pediatric Vaccines Market Forecast
10.3.3 Korea Adult and Pediatric Vaccines Market Forecast
10.3.4 Southeast Asia Adult and Pediatric Vaccines Market Forecast
10.3.5 India Adult and Pediatric Vaccines Market Forecast
10.3.6 Australia Adult and Pediatric Vaccines Market Forecast
10.4 Europe Adult and Pediatric Vaccines Forecast by Country (2023-2028)
10.4.1 Germany Adult and Pediatric Vaccines Market Forecast
10.4.2 France Adult and Pediatric Vaccines Market Forecast
10.4.3 UK Adult and Pediatric Vaccines Market Forecast
10.4.4 Italy Adult and Pediatric Vaccines Market Forecast
10.4.5 Russia Adult and Pediatric Vaccines Market Forecast
10.5 Middle East & Africa Adult and Pediatric Vaccines Forecast by Region (2023-2028)
10.5.1 Egypt Adult and Pediatric Vaccines Market Forecast
10.5.2 South Africa Adult and Pediatric Vaccines Market Forecast
10.5.3 Israel Adult and Pediatric Vaccines Market Forecast
10.5.4 Turkey Adult and Pediatric Vaccines Market Forecast
10.5.5 GCC Countries Adult and Pediatric Vaccines Market Forecast
10.6 Global Adult and Pediatric Vaccines Forecast by Type (2023-2028)
10.7 Global Adult and Pediatric Vaccines Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Information
11.1.2 GlaxoSmithKline Adult and Pediatric Vaccines Product Offered
11.1.3 GlaxoSmithKline Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 GlaxoSmithKline Main Business Overview
11.1.5 GlaxoSmithKline Latest Developments
11.2 Sanofi
11.2.1 Sanofi Company Information
11.2.2 Sanofi Adult and Pediatric Vaccines Product Offered
11.2.3 Sanofi Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Sanofi Main Business Overview
11.2.5 Sanofi Latest Developments
11.3 Merck
11.3.1 Merck Company Information
11.3.2 Merck Adult and Pediatric Vaccines Product Offered
11.3.3 Merck Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Merck Main Business Overview
11.3.5 Merck Latest Developments
11.4 Novartis
11.4.1 Novartis Company Information
11.4.2 Novartis Adult and Pediatric Vaccines Product Offered
11.4.3 Novartis Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Novartis Main Business Overview
11.4.5 Novartis Latest Developments
11.5 Pfizer
11.5.1 Pfizer Company Information
11.5.2 Pfizer Adult and Pediatric Vaccines Product Offered
11.5.3 Pfizer Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Pfizer Main Business Overview
11.5.5 Pfizer Latest Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Company Information
11.6.2 AstraZeneca Adult and Pediatric Vaccines Product Offered
11.6.3 AstraZeneca Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 AstraZeneca Main Business Overview
11.6.5 AstraZeneca Latest Developments
11.7 Johnson and Johnson
11.7.1 Johnson and Johnson Company Information
11.7.2 Johnson and Johnson Adult and Pediatric Vaccines Product Offered
11.7.3 Johnson and Johnson Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Johnson and Johnson Main Business Overview
11.7.5 Johnson and Johnson Latest Developments
11.8 Takeda Pharmaceutical
11.8.1 Takeda Pharmaceutical Company Information
11.8.2 Takeda Pharmaceutical Adult and Pediatric Vaccines Product Offered
11.8.3 Takeda Pharmaceutical Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Takeda Pharmaceutical Main Business Overview
11.8.5 Takeda Pharmaceutical Latest Developments
11.9 Bavarian Nordic
11.9.1 Bavarian Nordic Company Information
11.9.2 Bavarian Nordic Adult and Pediatric Vaccines Product Offered
11.9.3 Bavarian Nordic Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Bavarian Nordic Main Business Overview
11.9.5 Bavarian Nordic Latest Developments
11.10 LG Life Sciences
11.10.1 LG Life Sciences Company Information
11.10.2 LG Life Sciences Adult and Pediatric Vaccines Product Offered
11.10.3 LG Life Sciences Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 LG Life Sciences Main Business Overview
11.10.5 LG Life Sciences Latest Developments
11.11 Sinovac Biotech
11.11.1 Sinovac Biotech Company Information
11.11.2 Sinovac Biotech Adult and Pediatric Vaccines Product Offered
11.11.3 Sinovac Biotech Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Sinovac Biotech Main Business Overview
11.11.5 Sinovac Biotech Latest Developments
12 Research Findings and Conclusion
Table 1. Adult and Pediatric Vaccines Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Adult Vaccines
Table 3. Major Players of Pediatric Vaccines
Table 4. Adult and Pediatric Vaccines Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Adult and Pediatric Vaccines Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Adult and Pediatric Vaccines Market Size Market Share by Type (2017-2022)
Table 7. Adult and Pediatric Vaccines Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Adult and Pediatric Vaccines Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Adult and Pediatric Vaccines Market Size Market Share by Application (2017-2022)
Table 10. Global Adult and Pediatric Vaccines Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Adult and Pediatric Vaccines Revenue Market Share by Player (2020-2022)
Table 12. Adult and Pediatric Vaccines Key Players Head office and Products Offered
Table 13. Adult and Pediatric Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Adult and Pediatric Vaccines Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Adult and Pediatric Vaccines Market Size Market Share by Regions (2017-2022)
Table 18. Americas Adult and Pediatric Vaccines Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Adult and Pediatric Vaccines Market Size Market Share by Country (2017-2022)
Table 20. Americas Adult and Pediatric Vaccines Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Adult and Pediatric Vaccines Market Size Market Share by Type (2017-2022)
Table 22. Americas Adult and Pediatric Vaccines Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Adult and Pediatric Vaccines Market Size Market Share by Application (2017-2022)
Table 24. APAC Adult and Pediatric Vaccines Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Adult and Pediatric Vaccines Market Size Market Share by Region (2017-2022)
Table 26. APAC Adult and Pediatric Vaccines Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Adult and Pediatric Vaccines Market Size Market Share by Type (2017-2022)
Table 28. APAC Adult and Pediatric Vaccines Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Adult and Pediatric Vaccines Market Size Market Share by Application (2017-2022)
Table 30. Europe Adult and Pediatric Vaccines Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Adult and Pediatric Vaccines Market Size Market Share by Country (2017-2022)
Table 32. Europe Adult and Pediatric Vaccines Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Adult and Pediatric Vaccines Market Size Market Share by Type (2017-2022)
Table 34. Europe Adult and Pediatric Vaccines Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Adult and Pediatric Vaccines Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Adult and Pediatric Vaccines Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Adult and Pediatric Vaccines Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Adult and Pediatric Vaccines Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Adult and Pediatric Vaccines Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Adult and Pediatric Vaccines Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Adult and Pediatric Vaccines Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Adult and Pediatric Vaccines
Table 43. Key Market Challenges & Risks of Adult and Pediatric Vaccines
Table 44. Key Industry Trends of Adult and Pediatric Vaccines
Table 45. Global Adult and Pediatric Vaccines Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Adult and Pediatric Vaccines Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Adult and Pediatric Vaccines Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Adult and Pediatric Vaccines Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Adult and Pediatric Vaccines Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Adult and Pediatric Vaccines Market Size Market Share Forecast by Application (2023-2028)
Table 51. GlaxoSmithKline Details, Company Type, Adult and Pediatric Vaccines Area Served and Its Competitors
Table 52. GlaxoSmithKline Adult and Pediatric Vaccines Product Offered
Table 53. GlaxoSmithKline Adult and Pediatric Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. GlaxoSmithKline Main Business
Table 55. GlaxoSmithKline Latest Developments
Table 56. Sanofi Details, Company Type, Adult and Pediatric Vaccines Area Served and Its Competitors
Table 57. Sanofi Adult and Pediatric Vaccines Product Offered
Table 58. Sanofi Main Business
Table 59. Sanofi Adult and Pediatric Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Sanofi Latest Developments
Table 61. Merck Details, Company Type, Adult and Pediatric Vaccines Area Served and Its Competitors
Table 62. Merck Adult and Pediatric Vaccines Product Offered
Table 63. Merck Main Business
Table 64. Merck Adult and Pediatric Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Merck Latest Developments
Table 66. Novartis Details, Company Type, Adult and Pediatric Vaccines Area Served and Its Competitors
Table 67. Novartis Adult and Pediatric Vaccines Product Offered
Table 68. Novartis Main Business
Table 69. Novartis Adult and Pediatric Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Novartis Latest Developments
Table 71. Pfizer Details, Company Type, Adult and Pediatric Vaccines Area Served and Its Competitors
Table 72. Pfizer Adult and Pediatric Vaccines Product Offered
Table 73. Pfizer Main Business
Table 74. Pfizer Adult and Pediatric Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Pfizer Latest Developments
Table 76. AstraZeneca Details, Company Type, Adult and Pediatric Vaccines Area Served and Its Competitors
Table 77. AstraZeneca Adult and Pediatric Vaccines Product Offered
Table 78. AstraZeneca Main Business
Table 79. AstraZeneca Adult and Pediatric Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. AstraZeneca Latest Developments
Table 81. Johnson and Johnson Details, Company Type, Adult and Pediatric Vaccines Area Served and Its Competitors
Table 82. Johnson and Johnson Adult and Pediatric Vaccines Product Offered
Table 83. Johnson and Johnson Main Business
Table 84. Johnson and Johnson Adult and Pediatric Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Johnson and Johnson Latest Developments
Table 86. Takeda Pharmaceutical Details, Company Type, Adult and Pediatric Vaccines Area Served and Its Competitors
Table 87. Takeda Pharmaceutical Adult and Pediatric Vaccines Product Offered
Table 88. Takeda Pharmaceutical Main Business
Table 89. Takeda Pharmaceutical Adult and Pediatric Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. Takeda Pharmaceutical Latest Developments
Table 91. Bavarian Nordic Details, Company Type, Adult and Pediatric Vaccines Area Served and Its Competitors
Table 92. Bavarian Nordic Adult and Pediatric Vaccines Product Offered
Table 93. Bavarian Nordic Main Business
Table 94. Bavarian Nordic Adult and Pediatric Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. Bavarian Nordic Latest Developments
Table 96. LG Life Sciences Details, Company Type, Adult and Pediatric Vaccines Area Served and Its Competitors
Table 97. LG Life Sciences Adult and Pediatric Vaccines Product Offered
Table 98. LG Life Sciences Main Business
Table 99. LG Life Sciences Adult and Pediatric Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. LG Life Sciences Latest Developments
Table 101. Sinovac Biotech Details, Company Type, Adult and Pediatric Vaccines Area Served and Its Competitors
Table 102. Sinovac Biotech Adult and Pediatric Vaccines Product Offered
Table 103. Sinovac Biotech Adult and Pediatric Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 104. Sinovac Biotech Main Business
Table 105. Sinovac Biotech Latest Developments
List of Figures
Figure 1. Adult and Pediatric Vaccines Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Adult and Pediatric Vaccines Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Adult and Pediatric Vaccines Market Size Market Share by Type in 2021
Figure 7. Adult and Pediatric Vaccines in Hospitals
Figure 8. Global Adult and Pediatric Vaccines Market: Hospitals (2017-2022) & ($ Millions)
Figure 9. Adult and Pediatric Vaccines in Medical Care Centers
Figure 10. Global Adult and Pediatric Vaccines Market: Medical Care Centers (2017-2022) & ($ Millions)
Figure 11. Adult and Pediatric Vaccines in Others
Figure 12. Global Adult and Pediatric Vaccines Market: Others (2017-2022) & ($ Millions)
Figure 13. Global Adult and Pediatric Vaccines Market Size Market Share by Application in 2021
Figure 14. Global Adult and Pediatric Vaccines Revenue Market Share by Player in 2021
Figure 15. Global Adult and Pediatric Vaccines Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Adult and Pediatric Vaccines Market Size 2017-2022 ($ Millions)
Figure 17. APAC Adult and Pediatric Vaccines Market Size 2017-2022 ($ Millions)
Figure 18. Europe Adult and Pediatric Vaccines Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Adult and Pediatric Vaccines Market Size 2017-2022 ($ Millions)
Figure 20. Americas Adult and Pediatric Vaccines Value Market Share by Country in 2021
Figure 21. Americas Adult and Pediatric Vaccines Consumption Market Share by Type in 2021
Figure 22. Americas Adult and Pediatric Vaccines Market Size Market Share by Application in 2021
Figure 23. United States Adult and Pediatric Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Adult and Pediatric Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Adult and Pediatric Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Adult and Pediatric Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Adult and Pediatric Vaccines Market Size Market Share by Region in 2021
Figure 28. APAC Adult and Pediatric Vaccines Market Size Market Share by Application in 2021
Figure 29. China Adult and Pediatric Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Adult and Pediatric Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Adult and Pediatric Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Adult and Pediatric Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Adult and Pediatric Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Adult and Pediatric Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Adult and Pediatric Vaccines Market Size Market Share by Country in 2021
Figure 36. Europe Adult and Pediatric Vaccines Market Size Market Share by Type in 2021
Figure 37. Europe Adult and Pediatric Vaccines Market Size Market Share by Application in 2021
Figure 38. Germany Adult and Pediatric Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Adult and Pediatric Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Adult and Pediatric Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Adult and Pediatric Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Adult and Pediatric Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Adult and Pediatric Vaccines Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Adult and Pediatric Vaccines Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Adult and Pediatric Vaccines Market Size Market Share by Application in 2021
Figure 46. Egypt Adult and Pediatric Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Adult and Pediatric Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Adult and Pediatric Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Adult and Pediatric Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Adult and Pediatric Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Adult and Pediatric Vaccines Market Size 2023-2028 ($ Millions)
Figure 52. APAC Adult and Pediatric Vaccines Market Size 2023-2028 ($ Millions)
Figure 53. Europe Adult and Pediatric Vaccines Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Adult and Pediatric Vaccines Market Size 2023-2028 ($ Millions)
Figure 55. United States Adult and Pediatric Vaccines Market Size 2023-2028 ($ Millions)
Figure 56. Canada Adult and Pediatric Vaccines Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Adult and Pediatric Vaccines Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Adult and Pediatric Vaccines Market Size 2023-2028 ($ Millions)
Figure 59. China Adult and Pediatric Vaccines Market Size 2023-2028 ($ Millions)
Figure 60. Japan Adult and Pediatric Vaccines Market Size 2023-2028 ($ Millions)
Figure 61. Korea Adult and Pediatric Vaccines Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Adult and Pediatric Vaccines Market Size 2023-2028 ($ Millions)
Figure 63. India Adult and Pediatric Vaccines Market Size 2023-2028 ($ Millions)
Figure 64. Australia Adult and Pediatric Vaccines Market Size 2023-2028 ($ Millions)
Figure 65. Germany Adult and Pediatric Vaccines Market Size 2023-2028 ($ Millions)
Figure 66. France Adult and Pediatric Vaccines Market Size 2023-2028 ($ Millions)
Figure 67. UK Adult and Pediatric Vaccines Market Size 2023-2028 ($ Millions)
Figure 68. Italy Adult and Pediatric Vaccines Market Size 2023-2028 ($ Millions)
Figure 69. Russia Adult and Pediatric Vaccines Market Size 2023-2028 ($ Millions)
Figure 70. Spain Adult and Pediatric Vaccines Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Adult and Pediatric Vaccines Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Adult and Pediatric Vaccines Market Size 2023-2028 ($ Millions)
Figure 73. Israel Adult and Pediatric Vaccines Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Adult and Pediatric Vaccines Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Adult and Pediatric Vaccines Market Size 2023-2028 ($ Millions)
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...